2BB score and signals
Elicio Therapeutics, Inc.’s current 2BB score is 32 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 37 | Low |
| Momentum | 63 | Improving |
| Financial strength | 26 | Weak |
| Quality | 54 | Normal |
Company facts
| Headquarters | Boston, Massachusetts, United States |
| Founded | 2011 |
| Employees | 33 |
| 52-week range | $1.72 – $16.00 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-10 | — | -0.4185 | — | $0.00 |
| 2026-11-11 | — | -0.4383 | — | $0.00 |
| 2026-08-05 | — | -0.5477 | — | $0.00 |
| 2026-05-11 | -0.65 | -0.4743 | $0.00 | $0.00 |
Related companies
